Eiger BioPharmaceuticals, Inc.
EIGRQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $26 | $22 | $29 |
| Short-Term Investments | $0 | $73 | $67 | $100 |
| Receivables | $2 | $2 | $3 | $0 |
| Inventory | $2 | $3 | $3 | $0 |
| Other Curr. Assets | $9 | $14 | $9 | $9 |
| Total Curr. Assets | $38 | $118 | $103 | $138 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $17 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $5 | $4 |
| Total NC Assets | $1 | $3 | $23 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $39 | $120 | $127 | $144 |
| Liabilities | – | – | – | – |
| Payables | $2 | $9 | $8 | $5 |
| Short-Term Debt | $41 | $0 | $8 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $1 | $2 | $0 |
| Other Curr. Liab. | $10 | $16 | $14 | $11 |
| Total Curr. Liab. | $53 | $25 | $30 | $17 |
| LT Debt | $0 | $40 | $24 | $32 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | -$0 | $0 | $0 |
| Total NC Liab. | $0 | $40 | $24 | $32 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $53 | $65 | $54 | $49 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$512 | -$437 | -$340 | -$307 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $498 | $493 | $413 | $402 |
| Total Equity | -$14 | $55 | $72 | $95 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $39 | $120 | $127 | $144 |
| Net Debt | $16 | $14 | $10 | $4 |